Teratogenic hearing loss: a clinical perspective

J J Dyer1, B Strasnick, J T Jacobson

  • 1Department of Otolaryngology - Head and Neck Surgery, Eastern Virginia Graduate School of Medicine, Norfolk 23507, USA.

Insights

Environmental teratogens pose risks to infant hearing. Early recognition and prevention of exposure are crucial for reducing childhood hearing loss and deafness.

Area of Science:

  • Otolaryngology
  • Pediatrics
  • Environmental Health

Background:

  • Neonates are at risk for hearing loss, with environmental teratogens being significant contributing factors.
  • The Joint Committee on Infant Hearing has identified key indicators for neonatal hearing loss risk.
  • Environmental teratogens can adversely affect the developing auditory system.

Purpose of the Study:

  • To revisit and update the understanding of environmental teratogens impacting infant hearing.
  • To discuss clinical presentations, diagnostic findings, and treatment options for teratogen-induced hearing impairment.

Main Methods:

  • A comprehensive Medline literature search was conducted.
  • The search covered the latter half of the 20th century.
  • Literature reviewed focused on infectious, chemical, physical, and maternal teratogens affecting hearing.

Main Results:

  • Environmental teratogens are identified as critical risk factors for neonatal hearing loss.
  • Clinical, audiometric, electrophysiologic, and temporal bone findings associated with teratogenic exposure are presented.
  • Available treatment options for hearing impairment resulting from teratogenic exposure are discussed.

Conclusions:

  • Preventing and recognizing environmental teratogenic exposure is vital for reducing childhood hearing loss.
  • Early intervention and longitudinal follow-up are essential for managing affected infants.
Abstract